EPC2210000

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Cisplatin

Continue ReadingEPC2210000

EPY0001018

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Cisplatin impurity A - trans-diamminedichloroplatinium (II)

Continue ReadingEPY0001018

EPY0001019

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Cisplatin impurity B - amminetrichloroplatinate (-)

Continue ReadingEPY0001019

EPY0000855

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Citalopram for system suitability

Continue ReadingEPY0000855

EPY0001008

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Citalopram hydrobromide

Continue ReadingEPY0001008

EPY0001007

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Citalopram hydrochloride

Continue ReadingEPY0001007

EPA1202000

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Citric acid (anhydrous)

Continue ReadingEPA1202000

EPC2219000

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Citric acid monohydrate

Continue ReadingEPC2219000

EPY0000639

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Cladribine

Continue ReadingEPY0000639

EPY0000609

• Post author:adminlaboratory
• Post published:2022.06.09.
• Post category:
• Post comments:0 Comments

Cladribine for peak identification

Continue ReadingEPY0000609